VAXINIA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VAXINIA, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors [Phase 1]